"Dr. James Casella is a professor of pediatrics and oncology at the Johns Hopkins University School of Medicine. As the Johns Hopkins’ Rainey Professor of Pediatric Hematology, Dr. Casella is chief of the Division of Pediatric Hematology at Johns Hopkins Children's and director of the Basic and Translational Research Program in Sickle Cell Disease, Comprehensive Sickle Cell Center and the Maryland Hemophilia Treatment Center at Johns Hopkins. He supervises several labs investigating the cellular and molecular basis of pediatric blood-borne diseases. He is seeking to develop better treatments for sickle cell disease and the prevention of central nervous system complications of this disorder, including stroke. Dr. Casella received his undergraduate degree in mathematics from Union College. He earned his M.D. from SUNY of Syracuse and completed a residency in pediatrics at Johns Hopkins University School of Medicine, where he was subsequently a fellow in hematology/oncology. He has been a member of the Johns Hopkins’ faculty since 1983. A research scientist as well as a clinician, he co-directs the hematology/oncology fellowship program at Johns Hopkins Hospital and is an adjunct senior investigator (Pediatric Oncology Branch) in the Division of Clinical Sciences, National Cancer Institute, National Institutes of Health. He is also director of the NHLBI-funded K12 in benign hematology program at Johns Hopkins that trains young clinician/investigators in benign hematology and transfusion medicine. Dr. Casella has served on numerous university, hospital, and advisory committees, many geared toward hematology, pediatrics and transfusion. He has received many awards from the Johns Hopkins Hospital, including the Alexander ""Buck"" Schaffer Award for Outstanding Contribution to the Teaching of House Officers. He and a colleague created the Johns Hopkins/St. Agnes Comprehensive Hemophilia Clinic to improve care for patients with the disease.". Dr. Casella is rated as an Elite provider by MediFind in the treatment of Sickle Cell Disease. His top areas of expertise are Sickle Cell Disease, Congenital Hemolytic Anemia, Hemoglobinopathy, and Hemolytic Anemia.

Dr. Rakhi P. Naik is the Associate Director for the Division of Hematology at Johns Hopkins University. She also serves as Director of the Fellowship Hematology Track and Director of Organ Systems Foundation of Medicine (OSFM), the largest pre-clerkship course in the medical school. She holds an undergraduate degree in Biomedical & Electrical Engineering from Duke University, an M.D. with. Dr. Naik is rated as an Elite provider by MediFind in the treatment of Sickle Cell Disease. Her top areas of expertise are Sickle Cell Disease, Congenital Hemolytic Anemia, Hemolytic Anemia, and Hemoglobinopathy.

Dr. Lydia H. Pecker is a pediatric hematologist and Director of the Young Adult Clinic at the Sickle Cell Center for Adults at Johns Hopkins. Dr. Pecker received her undergraduate degree in Africana studies from Brown University and earned her M.D. at the University of Pennsylvania School of Medicine. She completed residency training at Children’s Hospital at Montefiore and completed a fellowship at Children’s National Medical Center and the National Institutes of Health’s National Heart, Lung and Blood Institute before joining the Hopkins faculty in 2016. Dr. Pecker's NIH and foundation-funded research focuses on reproductive health in people with ovaries and sickle cell disease. Dr. Pecker is rated as an Elite provider by MediFind in the treatment of Sickle Cell Disease. Her top areas of expertise are Sickle Cell Disease, Congenital Hemolytic Anemia, Hemoglobinopathy, Hemolytic Anemia, and Tubal Ligation.

Jennie Law is a Hematologist Oncology specialist and a Hospital Medicine provider in Baltimore, Maryland. Dr. Law is rated as an Elite provider by MediFind in the treatment of Sickle Cell Disease. Her top areas of expertise are Sickle Cell Disease, Hemoglobinopathy, Hemoglobin SC Disease, Hemoglobin E Disease, and Bone Marrow Aspiration. Dr. Law is currently accepting new patients.

Courtney Fitzhugh is a Pediatric Hematologist Oncology provider in Baltimore, Maryland. Dr. Fitzhugh is rated as an Elite provider by MediFind in the treatment of Sickle Cell Disease. Her top areas of expertise are Sickle Cell Disease, Congenital Hemolytic Anemia, Hemoglobinopathy, Hemolytic Anemia, and Bone Marrow Transplant.

Dr. Benjamin Bodnar is an Assistant Professor of Medicine and Pediatrics at the Johns Hopkins School of Medicine. He holds appointments as the Director of Quality and Safety for the Division of Hospital Medicine, Department of Medicine, as a Eudowood Scholar of Quality and Safety in the Division of Quality and Safety, Department of Pediatrics, and is affiliate faculty with the Armstrong Institute for Patient Safety and Quality at Johns Hopkins. He was born and raised in Baltimore and after training in institutions across the country, and working at sites around the world, he has settled back in his hometown. He received his undergraduate degree from Stanford University, his medical degree from Columbia University, and completed his specialty training at Yale New Haven Hospital. He also worked at Brigham and Women’s Hospital in Boston, MA, and held the appointment of an Instructor in Medicine at Harvard Medical School prior to joining Johns Hopkins in 2016. His focus on providing world-class clinical care to his patients at Johns Hopkins Hospital, he has a special interest in global health and the application of Quality Improvement techniques to the often poorly functional systems at work in resource-limited and developing health care environments. He has worked internationally at sites including Nepal, Mongolia, Ghana, Tanzania, Uganda, and Rwanda, and has worked with development groups including Partners in Health and The Millennium Villages Project. He is a faculty member of the Johns Hopkins Center for Global NCD Research and Training. As part of the Johns Hopkins Medicine COVID-19 response, he led the creation of standardized patient care guidelines for non-ICU COVID-19 patients across the health system. He also played a key role in the implementation of these guidelines via an Electronic Medical Record-integrated Clinical Decision Support platform, thus ensuring the evolving guidance is available to all providers at the point of care. Dr. Bodnar is rated as a Distinguished provider by MediFind in the treatment of Sickle Cell Disease. His top areas of expertise are Sickle Cell Disease, Hemoglobin C Disease, Hemoglobin E Disease, Endoscopy, and Gastrostomy.

Yudhishtra Markan is a Hematologist Oncology specialist and an Oncologist in Glen Burnie, Maryland. Dr. Markan is rated as an Experienced provider by MediFind in the treatment of Sickle Cell Disease. His top areas of expertise are Pleuropulmonary Blastoma, Lung Cancer, Familial Colorectal Cancer, and Colorectal Cancer.

Anisha Bassi is a primary care provider, practicing in Family Medicine in Glen Burnie,, Maryland. Dr. Bassi is rated as an Experienced provider by MediFind in the treatment of Sickle Cell Disease. Her top areas of expertise are Glucocorticoid-Remediable Aldosteronism, Hypertension, Familial Hypertension, Hernia Surgery, and Gastrostomy.

Kalpana Atluri is a primary care provider, practicing in Internal Medicine in Baltimore, Maryland. Dr. Atluri is rated as an Experienced provider by MediFind in the treatment of Sickle Cell Disease. Her top areas of expertise are Nephrosclerosis, Renovascular Hypertension, Maturity Onset Diabetes of the Young, and Glucocorticoid-Remediable Aldosteronism.

Maria Baer is a Hematologist Oncology specialist and a Hematologist in Baltimore, Maryland. Dr. Baer is rated as a Distinguished provider by MediFind in the treatment of Sickle Cell Disease. Her top areas of expertise are Acute Myeloid Leukemia (AML), Myelodysplastic Syndrome (MDS), Acute Promyelocytic Leukemia, Bone Marrow Aspiration, and Splenectomy. Dr. Baer is currently accepting new patients.

Dr. Jenna V. Canzoniero is an assistant professor in the Breast and Gynecological Malignancies Group at the Johns Hopkins Sidney Kimmel Cancer Center. She is a medical oncologist who specializes in treatment of patients with breast cancer. Dr. Canzoniero earned her medical degree and master's in bioinformatics from University of Michigan. She completed internal medicine residency at University of Maryland and served as Chief Resident. She joined the faculty at Johns Hopkins as an academic Hospitalist before pursuing her passion for oncology. She completed medical oncology fellowship at Johns Hopkins, including serving as Chief Fellow, and then re-joined the faculty as an oncologist. Her research focuses on expanding the use of molecular diagnostics, including liquid biopsy, to guide the treatment for patients with breast cancer. She is the liquid biopsy leader for the Johns Hopkins Molecular Tumor Board and leads the precision medicine initiative for the Breast and Gyn Malignancies Group. Previous awards include Director's Teaching Award in Clinical Science (2023) and the Marion Wright Award for Scientific Excellence (2024) from the Breast Cancer Research Fund. Dr. Canzoniero is rated as an Advanced provider by MediFind in the treatment of Sickle Cell Disease. Her top areas of expertise are Sickle Cell Disease, BRCA Positive Breast Cancer, Breast Cancer, Hemoglobinopathy, and Gastrostomy.

Dr. Robert Brodsky is a professor of medicine at the Johns Hopkins University School of Medicine. His area of clinical expertise is classical hematology and haploidentical bone marrow transplant for sickle cell disease and aplastic anemia. Dr. Brodsky serves as the director of the Division of Hematology and the T32 Training Program. He is the Johns Hopkins Family Professor of Medicine and Oncology. He received his M.D. from Hahnemann University. He completed his residency at the Vanderbilt University School of Medicine. He performed a fellowship in hematology at the National Institutes of Health and a fellowship in oncology at Johns Hopkins. He joined the Johns Hopkins faculty in 1997. From 2017 to 2022 he served as Associate Editor to The Journal of Clinical Investigation (JCI) and Secretary to American Society of Hematology (ASH). He serves as President of The American Society of Hematology (ASH) in 2023. Dr. Brodsky is rated as an Advanced provider by MediFind in the treatment of Sickle Cell Disease. His top areas of expertise are Paroxysmal Nocturnal Hemoglobinuria (PNH), Paroxysmal Cold Hemoglobinuria, Anemia, Bone Marrow Transplant, and Splenectomy.

Dr. Shruti Chaturvedi is an Associate Professor of Medicine at Johns Hopkins. She received her medical degree from Maulana Azad Medical College, University of Delhi, India. She then completed a residency in Internal Medicine at the Cleveland Clinic, Cleveland, OH, and a fellowship in Hematology and Oncology at Vanderbilt University, Nashville, TN. She has additionally obtained a Master of Science in Clinical Investigation (MSCI) degree from Vanderbilt University. Dr. Chaturvedi specializes in the care of adults with non-malignant hematologic disorders including thrombocytopenic purpura, atypical hemolytic uremic syndrome, antiphospholpiid syndrome, immune thrombocytopenia, autoimmune hemolytic anemia, thrombotic, other bleeding and clotting disorders, and anemias. Her research is focused on improving the care of patients with thrombotic microangiopathies with a focus on long term sequelae, and the role of complement in thrombotic disorders such as the antiphospholipid syndrome. Dr. Chaturvedi is rated as an Advanced provider by MediFind in the treatment of Sickle Cell Disease. Her top areas of expertise are Blood Clots, Atypical Hemolytic Uremic Syndrome (aHUS), Anemia, Splenectomy, and Bone Marrow Aspiration.

Dr. Bradley C. Strunk is an instructor of medicine at the Johns Hopkins University School of Medicine. His area of clinical expertise is internal medicine. Dr. Strunk is a hospitalist at Johns Hopkins Howard County Medical Center. Dr. Strunk earned his M.D. at Johns Hopkins. He completed his residency at Johns Hopkins Bayview Medical Center. Dr. Strunk is rated as an Advanced provider by MediFind in the treatment of Sickle Cell Disease. His top areas of expertise are Sickle Cell Disease, Renovascular Hypertension, Necrosis, Endoscopy, and Ureteroscopy.

Dr. Li Hua is a hospitalist at Johns Hopkins Howard County Medical Center. Dr. Hua only sees patients who are in the hospital, she does not have outpatient clinic appointments. Dr. Hua is rated as an Advanced provider by MediFind in the treatment of Sickle Cell Disease. Her top areas of expertise are Sickle Cell Disease, Sepsis, Ogilvie Syndrome, Hip Replacement, and Gastrostomy.

Dr. Cooke is Director of the Johns Hopkins Kimmel Cancer Center’s Pediatric Bone Marrow Transplantation Program. Prior to his appointment at Johns Hopkins, Dr. Cooke headed the Pediatric Blood and Marrow Transplantation Program at Rainbow Babies and Children’s Hospital, and University Hospitals Case Medical Center, in Cleveland, Ohio. He also co-directed the Hematologic Disorders Program of the Case Comprehensive Cancer Center at Case Western Reserve University. A nationally recognized transplantation immunology expert, Dr. Cooke focuses primarily on new strategies to prevent and treat graft-vs-host disease and lung complications following blood and bone marrow transplantation. His research efforts have been recognized by the Leukemia and Lymphoma Society and the American Society of Clinical Investigation. In addition to his younger patients, Dr. Cooke also cares for adolescents and young adults. Dr. Cooke is rated as an Experienced provider by MediFind in the treatment of Sickle Cell Disease. His top areas of expertise are Graft Versus Host Disease (GvHD), Chronic Graft Versus Host Disease (cGvHD), Anemia, Aplastic Anemia, and Bone Marrow Transplant.

Dr. Jodi Segal is a professor of medicine at the Johns Hopkins University School of Medicine. She has joint appointments in health policy and management, and epidemiology at the Johns Hopkins Bloomberg School of Public Health. Dr. Segal is internationally recognized as a clinician-investigator in comparative effectiveness research and pharmacoepidemiology. She trains investigators to conduct research to advance Johns Hopkins Medicine as a learning health system. She serves as the associate director of the Center for Health Services and Outcomes Research (CHSOR) and the co-director of the Center for Drug Safety and Effectiveness (CDSE), both in the School of Public Health. Dr. Segal received a B.S. from The Pennsylvania State University. She earned her M.D. from the University of Pittsburgh School of Medicine and her M.P.H. from the Johns Hopkins Bloomberg School of Public Health. She completed her residency at the University of Chicago and a fellowship in general nternal medicine at Johns Hopkins. She is a member of Phi Beta Kappa and Alpha Omega Alpha. Dr. Segal is rated as an Experienced provider by MediFind in the treatment of Sickle Cell Disease. Her top areas of expertise are Giant Papillary Conjunctivitis, Type 2 Diabetes (T2D), Vernal Keratoconjunctivitis, and Allergic Conjunctivitis.

Dr. Sara Mixter is Assistant Professor of Medicine and Pediatrics at the Johns Hopkins University School of Medicine. Her areas of clinical expertise are internal medicine, pediatrics, and primary care for adults with developmental disabilities and other complex childhood-onset conditions. She is the director of the Hopkins PACT (Pediatric-informed Adult Care and Transition) Clinic. Dr. Mixter is also the medical director of the Pediatric Complex Care Collaborative (PC3) for the Johns Hopkins Children’s Center. Dr. Mixter received her A.B. from Harvard College. She earned her M.D. from Harvard Medical School and M.P.H. from the Harvard School of Public Health. She completed her residency at Johns Hopkins as part of the inaugural group of trainees in the Urban Health Combined Internal Medicine-Pediatrics Residency Program. Her research interests include transitions of care for adolescents with special healthcare needs and education for residents and medical students, especially in primary care and complex care. Dr. Mixter has served as the Assistant Chief of Service for the Longcope firm of the Osler Medical Housestaff Training Program (2015-16), as well as Assistant Program Director for Ambulatory Education (2014-15). Dr. Mixter is rated as an Experienced provider by MediFind in the treatment of Sickle Cell Disease. Her top areas of expertise are Cerebral Palsy, Gastroparesis, Orbital Cellulitis, and Sickle Cell Disease.

Dr. Resar's studies molecular mechanisms leading to cancer, blood diseases, sickle cell anemia, hemophilia and other coagulopathies. Her research focuses on the HMG-I/Y gene family, which is widely overexpressed and functions as oncogenes in human cancers. Her laboratory recently developed transgenic mice overexpressing HMG-I; all mice develop aggressive lymphoid malignancy similar to leukemia and lymphoma in humans. Her studies also demonstrate that this gene is overexpressed in human lymphoid and other malignancies. Translational studies are underway to determine if overexpression of HMG-I is a marker for more aggressive human cancers. Resar's long-term goal is to develop more rational therapies that interfere with HMG-I/Y function in neoplastic transformation. Dr. Resar is rated as an Experienced provider by MediFind in the treatment of Sickle Cell Disease. Her top areas of expertise are Anemia, Sickle Cell Disease, and Immune Thrombocytopenic Purpura (ITP).

Recognized as a dedicated and compassionate pediatric hematologist-oncologist, Dr. Keates-Baleeiro cares for patients in the Division of Pediatric Hematology at Johns Hopkins Children’s Center in Baltimore, Maryland. A pediatric hematologist-oncologist is a physician who has special training and experience in diagnosing and treating blood disorders and cancers in children, teens, and young adults. Dr. Keates-Baleeiro’s current clinical interests include pediatric cytopenias, coagulation disorders, platelet disorders, sickle-cell anemia, and hemophilia. Her research interests include rare bleeding disorders, porphyria, and neutropenia in children. Dr. Keates-Baleeiro received her medical degree from the Drexel University College of Medicine in 1999 and completed her internship at Cohen Children’s Medical Center and her pediatric residency at Children’s Hospital of Michigan in Detroit in 2002. She then went on to complete a fellowship in pediatric hematology-oncology at the University of Michigan’s C.S. Mott Children’s Hospital and Vanderbilt University Medical Center in 2003 and 2006, respectively. Passionate about teaching, Dr. Keates-Baleeiro also serves as an Assistant Professor of Pediatrics at the Johns Hopkins School of Medicine educating medical students, pediatric residents, and pediatric hematology oncology fellows. Dr. Keates is rated as an Experienced provider by MediFind in the treatment of Sickle Cell Disease. Her top areas of expertise are Phosphoglycerate Kinase Deficiency, Sickle Cell Disease, Hemoglobin SC Disease, and Infantile Neutropenia.